1. Home
  2. APLM vs SGMA Comparison

APLM vs SGMA Comparison

Compare APLM & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • SGMA
  • Stock Information
  • Founded
  • APLM 2016
  • SGMA 1993
  • Country
  • APLM United States
  • SGMA United States
  • Employees
  • APLM N/A
  • SGMA N/A
  • Industry
  • APLM Blank Checks
  • SGMA Electrical Products
  • Sector
  • APLM Finance
  • SGMA Technology
  • Exchange
  • APLM Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • APLM 15.6M
  • SGMA 16.1M
  • IPO Year
  • APLM N/A
  • SGMA 1994
  • Fundamental
  • Price
  • APLM $0.13
  • SGMA $2.97
  • Analyst Decision
  • APLM Strong Buy
  • SGMA
  • Analyst Count
  • APLM 2
  • SGMA 0
  • Target Price
  • APLM $4.25
  • SGMA N/A
  • AVG Volume (30 Days)
  • APLM 872.1K
  • SGMA 27.6K
  • Earning Date
  • APLM 08-14-2024
  • SGMA 09-19-2024
  • Dividend Yield
  • APLM N/A
  • SGMA N/A
  • EPS Growth
  • APLM N/A
  • SGMA N/A
  • EPS
  • APLM N/A
  • SGMA N/A
  • Revenue
  • APLM $2,101,000.00
  • SGMA $360,530,443.00
  • Revenue This Year
  • APLM N/A
  • SGMA N/A
  • Revenue Next Year
  • APLM N/A
  • SGMA N/A
  • P/E Ratio
  • APLM N/A
  • SGMA N/A
  • Revenue Growth
  • APLM 70.54
  • SGMA N/A
  • 52 Week Low
  • APLM $0.11
  • SGMA $2.27
  • 52 Week High
  • APLM $2.15
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • APLM 45.47
  • SGMA 53.13
  • Support Level
  • APLM $0.13
  • SGMA $2.80
  • Resistance Level
  • APLM $0.17
  • SGMA $3.21
  • Average True Range (ATR)
  • APLM 0.01
  • SGMA 0.20
  • MACD
  • APLM 0.00
  • SGMA 0.06
  • Stochastic Oscillator
  • APLM 26.03
  • SGMA 67.19

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: